Scientists at the forefront of regenerative medicine, based at the esteemed Karolinska Institutet and KTH Royal Institute of Technology in…
Read More
Blood-Based Epigenetic Markers of Immune Cell Aging Reveal New Pathways for Precision Depression Diagnosis and Treatment
The landscape of psychiatric medicine is undergoing a fundamental shift as researchers move away from purely symptomatic assessments toward objective…
Read More
Discovery of Fam102a Protein as a Novel Bone Remodeling Factor Offers New Pathway for Osteoporosis Treatment
In a landmark study published in the journal Nature Communications on January 2, 2025, a research team led by Professor…
Read More
Scientists Uncover Potent Human Antibodies, Paving the Way for First-Ever Measles Treatment and Prevention
Scientists at the La Jolla Institute for Immunology (LJI) in California have achieved a significant breakthrough, becoming the first in…
Read More
Bioengineered Bone Marrow-on-a-chip Platform Developed by Penn Researchers Offers New Frontiers for Cancer Treatment and Space Medicine
Researchers from the University of Pennsylvania’s School of Engineering and Applied Science, the Perelman School of Medicine, and the Children’s…
Read More
Pioneering Unconventional Drug Delivery Systems Transform Cancer Treatment Landscape
The effectiveness of groundbreaking therapeutic agents is intrinsically linked to their successful and precise delivery within the human body. Without…
Read More
FDA Approves Langlara, an Interchangeable Biosimilar for Diabetes Management, Expanding Patient Access and Treatment Options
Sunshine Lake Pharma, Lannett Company, and its wholly owned subsidiary Lanexa Biologics have achieved a significant milestone in diabetes care…
Read More
Canadian Researchers Identify Potential Breakthrough in Glioblastoma Treatment Using Repurposed HIV Medication
A collaborative team of scientists from McMaster University and The Hospital for Sick Children (SickKids) has uncovered a significant biological…
Read More
Johns Hopkins Researchers Identify Key Protein and Gas Signaling Pathway as Potential Target for Alzheimer’s Disease Treatment
Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the understanding of Alzheimer’s disease, identifying a specific protein…
Read More
Chiesi Acquires KalVista Pharmaceuticals for $1.9 Billion, Bolstering Rare Disease Portfolio with On-Demand HAE Treatment
In a landmark move that marks the largest acquisition in its 90-year history, Italian pharmaceutical giant Chiesi has agreed to…
Read MoreYOU MAY HAVE MISSED
